Target Price | $65.28 |
Price | $34.94 |
Potential |
86.83%
register free of charge
|
Number of Estimates | 12 |
12 Analysts have issued a price target Magenta Therapeutics Inc 2026 .
The average Magenta Therapeutics Inc target price is $65.28.
This is
86.83%
register free of charge
$105.00
200.52%
register free of charge
$40.40
15.63%
register free of charge
|
|
A rating was issued by 19 analysts: 18 Analysts recommend Magenta Therapeutics Inc to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Magenta Therapeutics Inc stock has an average upside potential 2026 of
86.83%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 6.24 | 2.41 |
120.49% | 61.44% | |
Net Margin | -1,361.70% | -4,631.59% |
11.53% | 240.13% |
13 Analysts have issued a sales forecast Magenta Therapeutics Inc 2025 . The average Magenta Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
15 Magenta Therapeutics Inc Analysts have issued a net profit forecast 2025. The average Magenta Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.55 | -3.46 |
69.82% | 35.69% | |
P/E | negative | |
EV/Sales | 471.23 |
15 Analysts have issued a Magenta Therapeutics Inc forecast for earnings per share. The average Magenta Therapeutics Inc EPS is
This results in the following potential growth metrics and future valuations:
Magenta Therapeutics Inc...
Analyst | Rating | Action | Date |
---|---|---|---|
Clear Street |
Locked
➜
Locked
|
Locked | Sep 17 2025 |
Wedbush |
Locked
➜
Locked
|
Locked | Sep 12 2025 |
Stifel |
Locked
➜
Locked
|
Locked | Sep 12 2025 |
Baird |
Locked
➜
Locked
|
Locked | Sep 09 2025 |
Raymond James |
Locked
➜
Locked
|
Locked | Sep 09 2025 |
Guggenheim |
Locked
➜
Locked
|
Locked | Sep 09 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 08 2025 |
Analyst Rating | Date |
---|---|
Locked
Clear Street:
Locked
➜
Locked
|
Sep 17 2025 |
Locked
Wedbush:
Locked
➜
Locked
|
Sep 12 2025 |
Locked
Stifel:
Locked
➜
Locked
|
Sep 12 2025 |
Locked
Baird:
Locked
➜
Locked
|
Sep 09 2025 |
Locked
Raymond James:
Locked
➜
Locked
|
Sep 09 2025 |
Locked
Guggenheim:
Locked
➜
Locked
|
Sep 09 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 08 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.